Therapeutic Asset Ratings
2,003 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Azacitidine
Hematologic Disorder
M.D. Anderson Cancer Center
P2
B
(60)
Blinatumomab
Acute Myeloid Leukemia With BCR-ABL1
M.D. Anderson Cancer Center
P2
B
(60)
CABAZITAXEL
Prostate Small Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
Capivasertib
Endometrial Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
Capivasertib
Uterine Corpus Cancer
M.D. Anderson Cancer Center
P2
B
(60)
cc-5013
B-Cell Neoplasm
M.D. Anderson Cancer Center
P2
B
(60)
cc-5013
Metastatic Renal Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
Clofarabine
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P2
B
(60)
Clofarabine
Myelodysplastic Syndrome With Excess Blasts
M.D. Anderson Cancer Center
P2
B
(60)
Cyclophosphamide
Oral Cancer
M.D. Anderson Cancer Center
P2
B
(60)
Cytosin-Arabinosid
Acute Myeloid Leukemia With BCR-ABL1
M.D. Anderson Cancer Center
P2
B
(60)
Decitabine
Chronic Myeloid Leukemia
M.D. Anderson Cancer Center
P2
B
(60)
DEXAMETHASONE
B-Cell Neoplasm
M.D. Anderson Cancer Center
P2
B
(60)
DEXAMETHASONE
Relapsed/Refractory
M.D. Anderson Cancer Center
P2
B
(60)
Eloxatin
Refractory Malignant Neoplasm
M.D. Anderson Cancer Center
P2
B
(60)
Everolimus
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center
P2
B
(60)
Evomela
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
M.D. Anderson Cancer Center
P2
B
(60)
FENTANYL
AML
M.D. Anderson Cancer Center
P2
B
(60)
FILGRASTIM
High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
M.D. Anderson Cancer Center
P2
B
(60)
FILGRASTIM
Pre-transplant Purging
M.D. Anderson Cancer Center
P2
B
(60)
Fludarabine
Osteosarcoma
M.D. Anderson Cancer Center
P2
B
(60)
Hydroxychloroquine
Breast Carcinoma
M.D. Anderson Cancer Center
P2
B
(60)
Idarubicine
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer Center
P2
B
(60)
Immunoglobulin G1 [de-C-terminal-lysine], anti-(human CC chemokine receptor CCR8) (human-Mus musculus monoclonal BMS-986340 ?1-chain), disulfide with human-Mus musculus monoclonal BMS-986340 ?-chain, dimer
Colorectal Cancer
M.D. Anderson Cancer Center
P2
B
(60)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Philadelphia Chromosome Positive
M.D. Anderson Cancer Center
P2
B
(60)
Showing 276 to 300 of 2,003 assets
Previous
Page 12 of 81
Next